Phytotherapy versus hormonal therapy for postmenopausal bone loss: a meta-analysis
This meta-analysis found phytotherapy and hormonal therapy equally effective for bone mineral density, but phytotherapy had significantly fewer adverse events like uterine bleeding and breast pain.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This meta-analysis compared phytotherapy with hormonal therapy for postmenopausal bone loss, synthesizing data from 14 randomized controlled trials (780 patients) using 43 electronic databases, with trial quality assessed by Jadad’s scale and outcomes including bone mineral density (BMD) at lumbar, femoral, and forearm sites plus adverse events. Across trials, there were no significant differences in lumbar, femoral, or forearm BMD between phytotherapy and hormonal therapy. Incidence of uterine bleeding and breast pain was significantly lower with phytotherapy than with hormonal therapy, and the authors identified the six most commonly used herbs across included studies. A major caveat highlighted by the authors is that only four trials were graded as high quality (Jadad score 3–5), and they call for further high-quality trials, while the paper does not report strong evidence of added BMD efficacy beyond hormones. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (26)
- W12307800 via openalex
- W1593442063 via openalex
- W1598602811 via openalex
- W1659106200 via openalex
- W1946428167 via openalex
- W1976695523 via openalex
- W1978110341 via openalex
- W1986215651 via openalex
- W1992382272 via openalex
- W2002462361 via openalex
- W2009558420 via openalex
- W2023721609 via openalex
- W2048176475 via openalex
- W2087039880 via openalex
- W2104881987 via openalex
- W2127119599 via openalex
- W2137638342 via openalex
- W2150513168 via openalex
- W2151761687 via openalex
- W2152793561 via openalex
- W2157674770 via openalex
- W2160664144 via openalex
- W2166911020 via openalex
- W2367724837 via openalex
- W2402795502 via openalex
- W4253656064 via openalex
SciLite annotations
chemicals 1
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- scilite
- last seen: 2026-05-18T04:25:29.313245+00:00